Literature DB >> 17276226

Repair of full-thickness cartilage defects with cells of different origin in a rabbit model.

Hui Yan1, Changlong Yu.   

Abstract

PURPOSE: The purpose of this study was to evaluate the repaired tissues formed in full-thickness cartilage defects in a rabbit model implanted with 4 types of chondrogenic cells, including chondrocytes, mesenchymal stem cells (MSCs) and fibroblasts from rabbit, and human umbilical cord blood (hUCB) stem cells.
METHODS: Chondrocytes, MSCs, and fibroblasts were isolated from 6-week-old New Zealand rabbits; hUCB stem cells were isolated from the umbilical cord blood of newborn children. These 4 types of cells were cultured in vitro and embedded in polylactic acid (PLA) matrices. Full-thickness defects were produced in the femoral trochlear grooves of both knees in 36 adult New Zealand White rabbits. Cell/PLA composites were transplanted into cartilage defects. A total of 5 groups were formed according to implanted cell type: Group A, chondrocytes; Group B, MSCs; Group C, fibroblasts; Group D, hUCB stem cells; and Group E, no cells (control group). Repaired tissues were evaluated grossly, histologically, and immunohistochemically at 6 weeks and 12 weeks after implantation.
RESULTS: In Groups A and B, defects were repaired with hyaline-like cartilage. In Group C, defects were repaired with fibrous tissue. In Group D, defects were repaired primarily with fibrous tissue and scattered chondrocytes; in some specimens, defects were repaired with a thin layer of hyaline-like cartilage at 12 weeks. In Group E, defects were repaired with fibrous tissue. Histologic scores in Groups A and B were significantly higher than those in Groups C, D, and E at 6 and 12 weeks after transplantation.
CONCLUSIONS: Full-thickness cartilage defects treated with chondrocyte or MSC transplantation were repaired with hyaline-like cartilage tissue, and repair was significantly better than in tissues treated with fibroblasts and hUCB stem cells, as well as in the control group. Repaired tissues treated with MSCs appeared to have better cell arrangement, subchondral bone remodeling, and integration with surrounding cartilage than did repaired tissues generated by chondrocyte implantation. MSCs might be the most suitable cell source for cartilage repair. Further investigation into hUCB stem cell transplantation is needed. CLINICAL RELEVANCE: In our study of rabbits, MSCs supplied the most promising cell source for cartilage repair.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17276226     DOI: 10.1016/j.arthro.2006.09.005

Source DB:  PubMed          Journal:  Arthroscopy        ISSN: 0749-8063            Impact factor:   4.772


  44 in total

1.  Evaluating osteochondral defect repair potential of autologous rabbit bone marrow cells on type II collagen scaffold.

Authors:  Wei-Chuan Chen; Chao-Ling Yao; Yu-Hong Wei; I-Ming Chu
Journal:  Cytotechnology       Date:  2010-10-23       Impact factor: 2.058

Review 2.  Adipose-derived stem cells in functional bone tissue engineering: lessons from bone mechanobiology.

Authors:  Josephine C Bodle; Ariel D Hanson; Elizabeth G Loboa
Journal:  Tissue Eng Part B Rev       Date:  2011-04-08       Impact factor: 6.389

3.  Mesenchymal stromal cells from human perinatal tissues: From biology to cell therapy.

Authors:  Karen Bieback; Irena Brinkmann
Journal:  World J Stem Cells       Date:  2010-08-26       Impact factor: 5.326

4.  Mesenchymal stem cells: Molecular characteristics and clinical applications.

Authors:  Farbod Rastegar; Deana Shenaq; Jiayi Huang; Wenli Zhang; Bing-Qiang Zhang; Bai-Cheng He; Liang Chen; Guo-Wei Zuo; Qing Luo; Qiong Shi; Eric R Wagner; Enyi Huang; Yanhong Gao; Jian-Li Gao; Stephanie H Kim; Jian-Zhong Zhou; Yang Bi; Yuxi Su; Gaohui Zhu; Jinyong Luo; Xiaoji Luo; Jiaqiang Qin; Russell R Reid; Hue H Luu; Rex C Haydon; Zhong-Liang Deng; Tong-Chuan He
Journal:  World J Stem Cells       Date:  2010-08-26       Impact factor: 5.326

Review 5.  Therapeutic application of mesenchymal stem cells in bone and joint diseases.

Authors:  Yi Liu; Jianmei Wu; Youming Zhu; Jinxiang Han
Journal:  Clin Exp Med       Date:  2012-11-03       Impact factor: 3.984

6.  Immunogenicity of bovine and leporine articular chondrocytes and meniscus cells.

Authors:  Daniel J Huey; Johannah Sanchez-Adams; Vincent P Willard; Kyriacos A Athanasiou
Journal:  Tissue Eng Part A       Date:  2011-11-04       Impact factor: 3.845

7.  [Therapeutic utilization of stem cells in orthopedics].

Authors:  C Chiari; S Walzer; D Stelzeneder; M Schreiner; R Windhager
Journal:  Orthopade       Date:  2017-12       Impact factor: 1.087

Review 8.  The knee meniscus: structure-function, pathophysiology, current repair techniques, and prospects for regeneration.

Authors:  Eleftherios A Makris; Pasha Hadidi; Kyriacos A Athanasiou
Journal:  Biomaterials       Date:  2011-07-18       Impact factor: 12.479

9.  Variation of mesenchymal cells in polylactic acid scaffold in an osteochondral repair model.

Authors:  Yasushi Oshima; Frederick L Harwood; Richard D Coutts; Toshikazu Kubo; David Amiel
Journal:  Tissue Eng Part C Methods       Date:  2009-12       Impact factor: 3.056

10.  Sirtuin-1 (SIRT1) is required for promoting chondrogenic differentiation of mesenchymal stem cells.

Authors:  Constanze Buhrmann; Franziska Busch; Parviz Shayan; Mehdi Shakibaei
Journal:  J Biol Chem       Date:  2014-06-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.